Abiopharma

December 2025 Letter to Shareholders

PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors

Cessation Of Shareholding By Browny Healthcare Pte. Ltd.

Hologic - Hologic’s AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams

Hologic’s AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams

Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies

A New Press Release from Elicio Therapeutics

Revvity - Revvity Introduces Signals Xynthetica, an AI-Augmented Design Platform for Molecular and Materials Discovery

Natera - I-SPY 2 Publication in Nature Communications ShowsSignatera™ Can Predict Treatment Response and Recurrence Risk in Early-Stage Breast Cancer

NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor